or Try an Advanced Search...

    Innovative Therapies Stocks List

    Symbol Grade Name % Change
    OCGN B Ocugen, Inc. 1.79
    TLPH D Talphera, Inc. -6.97
    ATHA F Athira Pharma, Inc. 6.33
    AVTX F Avalo Therapeutics, Inc. -3.08
    ETNB F 89bio, Inc. -1.85
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices
    Related Stock Lists: Medicine Alcohol Biology Biomarkers Biopharmaceutical Blindness Brain Disorders Cancer Immunotherapy Diabetic Retinopathy Drug Development Drug Paraphernalia Eye Eye Diseases FDA Graft Versus Host Disease Hepatitis Host Disease Investigational Device Exemption Medical Equipment Medication

    Related ETFs - A few ETFs which own one or more of the above listed Innovative Therapies stocks.

    Symbol Grade Name Weight
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 3.7
    GERM B ETFMG Treatments Testing and Advancements ETF 0.94
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.67
    SBIO D ALPS Medical Breakthroughs ETF 0.54
    XBI D SPDR S&P Biotech ETF 0.49
    View all Innovative Therapies ETFs...
    Compare ETFs
    Compare GERM to SBIO Compare SURI to BBC Compare SURI to GERM

        Innovative Therapies Stocks Recent News

        Date Stock Title
        May 16 OCGN Nayax Posts Weak Q1 Results, Joins GameStop, Iris Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
        May 15 ATHA Athira Pharma GAAP EPS of -$0.69
        May 15 ATHA Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
        May 15 OCGN Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy
        May 15 OCGN Ocugen Inc (OCGN) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid ...
        May 15 OCGN Q1 2024 Ocugen Inc Earnings Call
        May 14 TLPH Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript
        May 14 TLPH AcelRx Pharmaceuticals GAAP EPS of -$0.16 beats by $0.06
        May 14 TLPH Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
        May 14 OCGN Ocugen, Inc. (OCGN) Q1 2024 Earnings Call Transcript
        May 14 OCGN Ocugen GAAP EPS of -$0.05 beats by $0.01, revenue of $1.01M
        May 14 ETNB 89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Compensated Cirrhosis
        May 14 OCGN Ocugen Provides Business Update with First Quarter 2024 Financial Results
        May 13 TLPH AcelRx Pharmaceuticals Q1 2024 Earnings Preview
        May 13 OCGN Ocugen Q1 2024 Earnings Preview
        May 13 AVTX Avalo Therapeutics reports Q1 results
        May 13 AVTX Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
        May 10 OCGN Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
        May 10 ETNB 89bio Inc (ETNB) Reports Increased Losses in Q1 2024 Despite Advancements in Clinical Trials
        May 10 OCGN Ocugen to Present at May 2024 Investor Conferences
        Related Industries: Biotechnology Medical Devices
        Related Stock Lists: Medicine Alcohol Biology Biomarkers Biopharmaceutical Blindness Brain Disorders Cancer Immunotherapy Diabetic Retinopathy Drug Development Drug Paraphernalia Eye Eye Diseases FDA Graft Versus Host Disease Hepatitis Host Disease Investigational Device Exemption Medical Equipment Medication
        Innovative Therapies

        Innovative Therapies is a term used to describe treatments that are new, cutting-edge, and often experimental. These therapies are designed to improve the quality of life for those suffering from a variety of medical conditions, including cancer, chronic pain, and neurological disorders. Examples of innovative therapies include gene therapy, stem cell therapy, and immunotherapy.

        Browse All Tags